Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AsiDNA with Re-irradiation in Recurrent Pediatric HGG
NCT05394558Phase 2Terminated
- Sponsor
- Institut Curie
- Start
- May 2022
- Primary completion
- Sep 2023
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of asidna in high-grade glioma (HGG), sponsored by Institut Curie. Started May 2022; status: terminated.
02
Drugs
asidna
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT05394558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05394558.